remestemcel-l Report issue

Cell therapy Experimental
AACT ChEMBL

Active Ingredient History

NOW
  • Now

Chemistry

More Chemistry

Pharmacology

Alternative names

jr-0301 | prochymal | remestemcel-l

Organizations (10)

Research & Development (10)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (13)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (13)


 

Bronchitis, Chronic (Phase 2)

Colitis, Ulcerative (Phase 1/Phase 2)

COVID-19 (Phase 3)

Crohn Disease (Phase 3)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 1 (Phase 2)

Drugs, Investigational (Phase 3)

Graft vs Host Disease (Phase 3)

Mesenchymal Stem Cells (Phase 3)

Myocardial Infarction (Phase 2)

Pulmonary Disease, Chronic Obstructive (Phase 2)

Pulmonary Emphysema (Phase 2)

Respiratory Distress Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 18
  • # of Trial Organizations: 10

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue